China, Japan and America: Face-off | The Economist
US Airlines to Comply With China Defense Zone | Voice of America
Airlines Urged by U.S. to Give Notice to China | NYTimes.com
＜在日中国人の目＞張子の虎はだれだ？ 防空圏問題 | 大紀元
An anti-Samsung bias in Japan is one reason Apple is thriving there
Ben Thompson @monkbent
Japan has been one of Apple’s best international markets for decades. So why is iPhone success surprising?
WSJ: ‘Apple Finds Surprising Growth Market in Japan’ | Daring Fireball
Why is the word “surprising” in this headline:
The iPhone was already the best-selling smartphone in Japan, before it was available on the country’s largest carrier, and somehow it’s “surprising” that Japan is a growth market?
WSJ: Apple Finds Surprising Growth Market in Japan | stratēchery by Ben Thompson
Nowhere is that truer than in Japan, which lost 1.3 million millionaires between June 2012 and June 2013, according to Credit Suisse’s Global Wealth report (pdf) released earlier this week.
The overwhelming majority of its profits—some 75% of Aflac’s pre-tax earnings in 2012—come from Japan and have done so for years. The company’s position in Japan has helped Aflac consistently outpace the industry average in profit growth. And the cornerstone of Aflac’s Japan business is one incredibly bleak-sounding product line: Cancer insurance.
If your business thrived on a healthy fear of cancer, there were few better places to be than Japan in the 1970s. Cancer was in the midst of a decades long climb that would eventually make it Japan’s top killer in 1981. It remains the number one cause of death in Japan.
In Japan, there was plenty of fear. There was also plenty of demand for insurance. (It remains one of the world’s largest insurance markets.) And there wasn’t a lot of something else: Competition.
It was seen as a small concession to the US, which had been hammering Japan on opening its rather closed economy. In an interview with the Atlanta Journal Constitution back in 2000, an insurance industry analyst summed up the view of Japanese policy makers: “Nobody is going to buy dreaded disease insurance, so let’s give it to the Americans. Let them have it.”
But they did buy it. Oh boy, did they, as some of Japan’s largest corporations gave their stamp of approval to Aflac’s offerings.
And the list of participating companies reads like a roll-call of Japan Inc.—Hitachi, Sony, Toyota, Nissan, Dai-Ichi Kangyo Bank, Sumitomo Bank, Mitsui, Mitsubishi and thousands of others.